Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group.
A prospective randomised multicentre clinical study was undertaken for 2 years and 3 months from November 1982, with the aim of examining the significance of using a combination of ftorafur (FT) and tamoxifen (TAM) for post-operative adjuvant therapy of breast cancer. Patients had either stage II or...
Main Authors: | , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
1994
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968816/ |